Sophie Herbert
Overview
Explore the profile of Sophie Herbert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmed N, Herbert S, Arenas-Pinto A, Rickman H, Benn P, Edwards S, et al.
Int J STD AIDS
. 2023 Sep;
35(1):71-73.
PMID: 37728103
People living with HIV (PLWH) are at higher risk of reactivation of Chagas disease, a neglected tropical disease, caused by . There are no data from UK HIV clinics on...
2.
Smith S, Calthorpe R, Herbert S, Smyth A
Cochrane Database Syst Rev
. 2023 Feb;
2:CD013733.
PMID: 36734528
Background: Improved understanding and treatment of cystic fibrosis (CF) has led to longer life expectancy, which is accompanied by an increasingly complex regimen of treatments. Suboptimal adherence to the treatment...
3.
LeVoir H, Cochrane E, Ashby J, Herbert S
Sex Transm Infect
. 2022 Jul;
98(5):394.
PMID: 35878928
No abstract available.
4.
Herbert S, Rowbotham N, Smith S, Wilson P, Elliott Z, Leighton P, et al.
Thorax
. 2021 Sep;
77(3):295-297.
PMID: 34556553
Reducing treatment burden in cystic fibrosis (CF) is the top research priority for patients and clinicians. Difficulty accessing medication is one aspect of treatment burden. We investigated this with an...
5.
Whitlock G, Protopapas K, Bernardino J, Imaz A, Curran A, Stingone C, et al.
HIV Med
. 2021 Aug;
22(10):944-957.
PMID: 34432363
Introduction: Chemsex in a European context is the use of any of the following drugs to facilitate sex: crystal methamphetamine, mephedrone and gamma-hydroxybutyrate (GHB)/gamma-butyrolactone (GBL) and, to a lesser extent,...
6.
Evans R, Herbert S, Owen W, Rao D
BMJ Case Rep
. 2021 Apr;
14(4).
PMID: 33837028
We present a case of a 38-year-old man with no medical comorbidities who presented to the hospital with haemoptysis and shortness of breath on a background of vaping home-manufactured cannabis...
7.
Smith S, Rowbotham N, Davies G, Gathercole K, Collins S, Elliott Z, et al.
BMJ Open Respir Res
. 2020 Sep;
7(1).
PMID: 32900780
Introduction: Relieving gastrointestinal (GI) symptoms was identified as a 'top ten' priority by our James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF). We conducted an online survey to...
8.
Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials
Davies G, Rowbotham N, Smith S, Elliot Z, Gathercole K, Rayner O, et al.
J Cyst Fibros
. 2019 Nov;
19(3):499-502.
PMID: 31735561
In a recent James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF) the top priority clinical research question was: "What are effective ways of simplifying the treatment burden of...
9.
10.